Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Feedburner
Share Us

UBI-HSR 2017 - II International Congress in Health Sciences Research: Towards Innovation and Entrepreneurship-“Trends in Biotechnology for Biomedical Applications”

View: 1036

Website http://www.ubihealthsciencesresearch.pt/ | Edit Freely

Category Biotechnology, Biomedical Applications, Entrepreneurship, Health Sciences

Deadline: March 17, 2017 | Date: May 17, 2017-May 20, 2017

Venue/Country: Covilhã, Portugal

Updated: 2016-12-06 20:35:53 (GMT+9)

Call For Papers - CFP

The 2nd edition of the International Congress in Health Sciences Research presents an excellent opportunity to academic and industrial experts interchange knowledge and build new networks with young and senior researchers, improving the discussion of new scientific ideas. This event will focus in biotechnology applied to biomedical research. Major topics in discussion will include Pharmaceutical Biotechnology, Genetic Engineering and Molecular Biotechnology, Regenerative Medicine, Nanobiotechnology, Bioinformatics and Biosensors, Bioprocess Engineering and Omics. Moreover, an entrepreneurship approach will also be explored through the participation of pharmaceutical and biotechnological companies.

UBI-HSR 2017 is also a great opportunity to visit Covilhã, a “mountain city” known as town of wool and snow or as the "Portuguese Manchester", rare in Portuguese urbanism with the expression of a vast industrial tradition based on modern and contemporary times. This pleasant city provides an amazing scenario for an outstanding scientific discussion.


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.